Free CME from PeerView


Allergy & Immunology CME

Medical Learning Institute, Inc.
Therapeutic Advancements in Myelodysplastic Syndromes: Bridging the Gap Between Patient Safety and Quality Care Through the Latest Science and Evidence-Based Learning in Nursing Practice
Sara M. Tinsley, PhD, APRN, AOCN
May 07, 2021
Medical Learning Institute, Inc.
Visualizing Progress for TP53-Mutant AML: A Pathology-Guided Journey Through Diagnostic Principles and Modern Treatment
Joseph D. Khoury, MD, FCAP
May 05, 2021
Medical Learning Institute, Inc.
The Rise of B-Cell Therapies in Relapsing MS: Examining the State of the Science, New Therapeutic Options, and Patient-Centered Clinical Decision-Making
Ludwig Kappos, MD, FEAN, FAAN
May 04, 2021
Medical Learning Institute, Inc.
A New Era of Migraine Management: Recent Updates on Recognition, Acute Treatment, and Prevention for Emergency Physicians
Benjamin W. Friedman, MD, MS, FAAEM, FACEP, FAHS
May 03, 2021
Medical Learning Institute, Inc.
Simulation – Striking a Balance: Weighing the Benefits and Risks of Treatment With Direct Oral Anticoagulants in Individuals With Nonvalvular Atrial Fibrillation or Venous Thromboembolism
Sean Pokorney, MD, MBA
April 21, 2021
Penn State College of Medicine
The Therapeutic Transformation of Bladder Cancer: Understanding Immune-, Targeted-, and Antibody-Based Models for Patient Care
Matthew D. Galsky, MD
April 20, 2021
Medical Learning Institute, Inc.
Optimizing Care for High-Risk Myeloid Cancers: Interprofessional Team Insights From a Center of Excellence
Naval Daver, MD
April 14, 2021
Medical Learning Institute, Inc.
Applying Evidence to Practice: Updated Consensus Recommendations for the Diagnosis, Surveillance, and Management of Tuberous Sclerosis Complex
Elizabeth A. Thiele, MD, PhD
April 14, 2021
Matthew S. Johnson, MD, FSIR / Richard S. Finn, MD
Medical Learning Institute, Inc.
At the Nexus of Locoregional and Systemic Liver Cancer Therapy: A Multidisciplinary Tumor Board on Improving Outcomes in Intermediate to Advanced HCC
Matthew S. Johnson, MD, FSIR / Richard S. Finn, MD
April 14, 2021
Dara L. Aisner, MD, PhD / Joshua Bauml, MD
Medical Learning Institute, Inc.
Precision Decisions in Genomic Testing and Targeted Treatment of NSCLC
Dara L. Aisner, MD, PhD / Joshua Bauml, MD
April 13, 2021
Medical Learning Institute, Inc.
Optimizing Patient Outcomes in RCC Through Safe and Efficacious Use of Immuno-Oncology and Targeted Approaches: Teaming Up to Mitigate and Manage Adverse Events and Maximize Survival
Brian I. Rini, MD, FASCO
April 12, 2021
Medical Learning Institute, Inc.
The Path Forward for Immunotherapy in Resectable Melanoma: Principles and Perspectives on Using Immune-Based Adjuvant and Neoadjuvant Therapy
Jennifer Wargo, MD, MMSc
April 12, 2021
Medical Learning Institute, Inc.
Addressing the Unmet Needs of Patients With Moderate to Severe Alopecia Areata: A Visual Exploration of Disease Pathogenesis and the Clinical Potential of Novel Therapeutic Options
Brett King, MD, PhD
April 08, 2021
Medical Learning Institute, Inc.
HER2 and HER3 Alterations as Therapeutic Targets of Increasing Significance in Solid Tumors: Implications for Pathology and Oncology Practice
Kurt A. Schalper, MD, PhD
April 06, 2021
Hossein Borghaei, DO, MS / Sanjay Mukhopadhyay, MD
Medical Learning Institute, Inc.
The Nuances of Immunotherapy Biomarker Testing in Solid Tumors: Unraveling Complexities and Overcoming Challenges to Improve Outcomes
Hossein Borghaei, DO, MS / Sanjay Mukhopadhyay, MD
April 05, 2021
Medical Learning Institute, Inc.
Conversations on the New Wave of Innovative Therapy in Follicular Lymphoma: Implications for Personalized Medicine
John M. Pagel, MD, PhD
April 05, 2021
Medical Learning Institute, Inc.
Simulation – Partnering With Peers and Patients: Achieving T2DM Treatment Goals With GLP-1 RA Therapy
Jay H. Shubrook, DO, FAAFP, FACOFP
March 31, 2021
Medical Learning Institute, Inc.
Data-Based Updates: Practical Application of Recent Evidence on Disease-Modifying Therapies for SMA
Crystal M. Proud, MD
March 30, 2021
Penn State College of Medicine
A Visual Guide to B-Cell Therapies in Relapsing MS: Clarifying the Options in an Expanding Treatment Landscape
Edward J. Fox, MD, PhD
March 26, 2021
Medical Learning Institute, Inc.
Rewriting the Rules for Early Cancer Screening: Case-Based Insight on Primary Care Principles for Using Blood-Based Screening Techniques
John J. Russell, MD
March 25, 2021
University of Florida College of Medicine / Medical Learning Institute, Inc.
New Insights: How Does Real-World Evidence Influence VTE Management? A Visual Exploration of Real-World Studies of DOACs
Alexander (Ander) Cohen, MB BS (Hons), MSc, MD, FRACP, FESC
March 23, 2021
Medical Learning Institute, Inc.
Expert Perspectives on the Early Diagnosis of Alzheimer’s Disease and the Promise of Novel Therapies on the Horizon
Marwan Sabbagh, MD, FAAN, CCRI
March 22, 2021
Medical Learning Institute, Inc.
Innovative Blood-Based Screening in Cancer Care: State of the Science and Future Opportunities for Accelerating Cancer Diagnoses
Minetta C. Liu, MD
March 18, 2021
Penn State College of Medicine
Test Your Knowledge: The Evidence for GABA-Modulating Neuroactive Steroids as a New Class of Rapid-Acting Antidepressants
Kristina M. Deligiannidis, MD
March 16, 2021
Medical Learning Institute, Inc.
Adopting Telemedicine and Digital Tools for Nonvalvular Atrial Fibrillation Management and Stroke Prevention
Khaldoun G. Tarakji, MD, MPH
March 12, 2021
Medical Learning Institute, Inc.
New Milestones and Changing Standards of Care in EGFR-Mutated NSCLC: Expanding the Benefits of Genomic Testing and EGFR-Targeted Therapy to Early-Stage Lung Cancer
March 09, 2021
Medical Learning Institute, Inc.
IL-17 Inhibitors in Nonradiographic Axial Spondyloarthritis: Expert Insight on Clinical Decision-Making in an Expanding Therapeutic Landscape
Philip J. Mease, MD, MACR
March 04, 2021
Medical Learning Institute, Inc.
RCC MasterClass and Clinical Consult: Remodeling the Treatment Algorithm With Novel Immune and Targeted Therapies
Toni K. Choueiri, MD
March 04, 2021
Medical Learning Institute, Inc.
Making the Right Moves in the Evolving Prostate Cancer Therapeutic Landscape: Expert Guidance on Treatment Sequencing and Selection for Effective Management Across the Disease Continuum
Robert Dreicer, MD, MS, MACP, FASCO
March 03, 2021
Medical Learning Institute, Inc.
Examining the State of the Science on New Therapies in Bladder Cancer: Perspectives on the Latest Developments Across the Disease Continuum
Professor Thomas Powles, MBBS, MRCP, MD
March 03, 2021

Pages

Upcoming Live Events

Education Collections

Recent CME Podcast

More Podcasts from PeerView